alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 31.1** **HORIZON LINES,    INC. CERTIFICATIONS**     I, Charles G. Raymond, President and Chief Executive Officer,    certify that:      1.      I have reviewed this report on    Form 10-K    of Horizon Lines, Inc.;      2.      Based on my knowledge, this report does not contain any untrue    statement of a material fact or omit to state a material fact    necessary to make the statements made, in light of the    circumstances under which such statements were made, not    misleading with respect to the period covered by this report;      3.      Based on my knowledge, the financial statements, and other    financial information included in this report, fairly present in    all material respects the financial condition, results of    operations and cash flows of the registrant as of, and for, the    periods presented in this report;      4.      The registrant’s other certifying officer and I are    responsible for establishing and maintaining disclosure controls    and procedures (as defined in Exchange Act    Rules 13a-15(e)    and    15d-15(e))    for the registrant and have:      a)      Designed such disclosure controls and procedures, or caused such    disclosure controls and procedures to be designed under our    supervision, to ensure that material information relating to the    registrant, including its consolidated subsidiaries, is made    known to us by others within those entities, particularly during    the period in which this report is being prepared;      b)      Evaluated the effectiveness of the registrant’s disclosure    controls and procedures and presented in this report our    conclusions about the effectiveness of the disclosure controls    and procedures, as of the end of the period covered by this    report based on such evaluation; and      c)      Disclosed in this report any change in the registrant’s    internal control over financial reporting that occurred during    the registrant’s most recent fiscal quarter that has    materially affected, or is reasonably likely to materially    affect, the registrant’s internal control over financial    reporting; and      5.      The registrant’s other certifying officer and I have    disclosed, based on our most recent evaluation of internal    control over financial reporting, to the registrant’s    auditors and the audit committee of the registrant’s board    of directors (or persons performing the equivalent functions):      a)      All significant deficiencies and material weaknesses in the    design or operation of internal control over financial reporting    which are reasonably likely to adversely affect the    registrant’s ability to record, process, summarize and    report financial information; and      b)      Any fraud, whether or not material, that involves management or    other employees who have a significant role in the    registrant’s internal control over financial reporting.     Date: February 6, 2008 /s/  Charles    G. Raymond**Charles G. Raymond****President and Chief Executive    Officer****(Principal Executive    Officer)**
Amendment to Employment Agreement dated February 1, 1998



 Exhibit 10.7 
 January 18, 2000 
 Mr. Richard Yarwood 
 [Home Address] 
  

	 	Re:	Employment Agreement Amendment 

 Dear Richard, 
 This letter serves to amend your Employment Agreement with R.P. Scherer Corporation dated February 1, 1998. 
 Specifically, this amends Section 2(a) and 2(b) to reflect your new title and responsibilities as President, Zydis. 
 All other terms of the Agreement remain in effect unless they have already been satisfied (as in the case of Section 3(b-v)) or amended as a result of the merger
with Cardinal Health (as in the case of stock option participation as governed by separate stock option agreements). 
 Regards, 
 /s/ George Fotiades
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr.

, Chief Justice

Michael F. Cavanagh

Stephen J. Markman

Mary Beth Kelly

Brian K. Zahra

Bridget M. McCormack

David F. Viviano

, Justices 

# Order

December 30, 2014

148317

- 23(76)

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 148317

COA: 308104

Oakland CC: 2011

- 236622

- FH

BARBARA MIRA JOHNSON,

Defendant

- Appellant.

_________________________________________/

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 148318

COA: 308105

Oakland CC: 2011

- 236623

- FH

ANTHONY JAMES AGRO,

Defendant

- Appellant.

_________________________________________/

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 148319

COA: 308106

Oakland CC: 2011

- 236624

- FH

RYAN MICHAEL FLEISSNER,

Defendant

- Appellant.

_________________________________________/

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 148320

COA: 308109

Oakland CC: 2011

- 236625

- FH

BARBARA JEAN AGRO,

Defendant

- Appellant.

_________________________________________/I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

December 30, 2014

d1215 2

Clerk PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 148321

COA: 308110

Oakland CC: 2011

- 236626

- FH

RYAN DANIEL RICHMOND,

Defendant

- Appellant.

_________________________________________/

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 148322

COA: 308111

Oakland CC: 2011

- 236627

- FH

MATTHEW CURTIS,

Defendant

- Appellant.

_________________________________________/

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 148323

COA: 308113

Oakland CC: 2011

- 236628

- FH

NICHOLAS AGRO,

Defendant

- Appellant.

_________________________________________/

On order of the Court, the motion for reconsideration of this Court’s June 11, 2014

order is considered, and it is DEN IED, because it does not appear that the order was

entered erroneously.
**Exhibit
      32.1**


**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with this Amendment No. 1 to the Quarterly Report on Form 10-Q of
      Xcorporeal, Inc. (the “Company”) for the quarter ended March 31, 2008, as filed
      with the Securities and Exchange Commission on the date hereof (the “Report”),
      I, Terren S. Peizer, Executive Chairman of the Company, certify, pursuant to
      18
      U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,
      that:





(1)
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.






/s/
                Terren S. Peizer
            Date:
                August 1, 2008Terren
                S. Peizer
              Executive
                Chairman
NOTICE: NOT FOR OFFICIAL PUBLICATION. UNDER ARIZONA RULE OF THE SUPREME COURT 111(c), THIS DECISION IS NOT PRECEDENTIAL AND MAY BE CITED ONLY AS AUTHORIZED BY RULE

.

IN THE 

## A RIZONA 

## C OURT OF 

## A PPEALS

D IVISION O NE

STATE OF ARIZONA , Respondent ,

v.
CHARLES TAYLOR CROCKETT , Petitioner

. No. 1 CA

- CR 21

- 0 341 PRPC

Petition for Review from the Superior Court in Maricopa County

No. CR201 1

- 006752

- 003 The Honorable Ronee Korbin Steiner , Judge REVIEW GRANTED; RELIEF DENIED

COUNSEL Maricopa County Attorney ’ s Office , Phoenix By Amanda M. Parker Counsel for Respondent The Law Office of Stephen L. Crawford, P.L.L.C. , Phoenix By Stephen L. Crawford Counsel for Petitioner FILED 1-13-2022STATE v. CROCKETT Decision of the Court

2 MEMORANDUM DECISION Presiding Judge D. Steven Williams, Judge David B. Gass , and Judge James B. Morse Jr. delivered the decision of the Court

.

PER CURIUM : ¶1 Petitioner Charles Taylor Crockett seeks review of the superior court’s order denying his petition for post

- conviction relief

. This is petitioner’s latest successive petition. ¶2 Absent an abuse of discretion or error of law, this court will not disturb a superior court’s ruling on a petition for post

- conviction relief. State v. Gutierrez , 229 Ariz. 573, 577, ¶ 19, 278 P.3d 1276, 1280 (2012). It is petitioner’s burden to show that the superior court abused its discretion by denying the petition for post

- conviction relief. See State v. Poblete , 227 Ariz. 537, ¶ 1, 260 P.3d 1102, 1103 (App. 2011) (petitioner has burden of establishing abuse of discretion on review). ¶3 We have reviewed the record in this matter, the superior court’s order denying the petition for post

- convicti on relief , and the petition for review. The petitioner has failed to show an abuse of discretion. ¶4 For the foregoing reasons, this court grants review but denies relief.
Court of Appeals of the State of Georgia

Clerk's Office, Atlanta, January 07, 2019.

I certify that the above is a true extract from the minutes 

of the Court of Appeals of Georgia.

Witness my signature and the seal of said court hereto 

affixed the day and year last above written.

, Clerk.

Court of Appeals 

of the State of Georgia

ATLANTA, January 07, 2019

The Court of Appeals hereby passes the following order

A19A0598. HELENA BRUNDIDGE v. U.S. BANK NATIONAL ASSOCIATION et al..

The appellant in this case failed to comply with the notice of docketing mailed by this 

Court and with Court of Appeals Rule 23 (a), regarding the filing of an enumeration of errors 

and brief within twenty days after the appeal was docketed. See also Court of Appeals Rule 13.

On December 19, 2018, this Court ordered the appellant to file an enumeration of errors 

and a brief no later than December 31, 2018. As of the date of this order, the appellant's 

enumeration of errors and brief still have not been filed. Accordingly, this appeal is deemed 

abandoned and is hereby ordered DISMISSED. Court of Appeals Rules 7, 23 (a).
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2595 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2595

     To extend the suspension of duty on phosphoric acid, tris (2-
                           ethylhexyl) ester.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

 Mr. Carper (for himself and Mr. Coons) introduced the following bill; 
     which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
     To extend the suspension of duty on phosphoric acid, tris (2-
                           ethylhexyl) ester.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PHOSPHORIC ACID, TRIS (2-ETHYLHEXYL) ESTER.

    (a) In General.--Heading 9902.24.62 of the Harmonized Tariff 
Schedule of the United States (relating to phosphoric acid, tris (2-
ethylhexyl) ester) is amended by striking the date in the effective 
period column and inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
Adam Douglas LAINEY, Appellant, v. Lorna Beth FOUNTAIN, individually and o/b/o A.G.L., a minor, Appellee.

Case No. 2D16-5105

District Court of Appeal of Florida, Second District.

Opinion filed December 27, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
EXHIBIT 32.2
 
 CERTIFICATION PURSUANT TO
 18 U.S.C. 1350,
 AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
 In connection with the Annual Report of Two Rivers Water Company on Form 10-K for the year ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Wayne Harding, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
 The Report fully complies with the requirements of Section 13(a) or 15(d) of the
 Securities Exchange Act of 1934; and
 
 The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
 Dated:  March 29, 2011
By: /s/ Wayne HardingChief Financial Officer & Principal Accounting Officer
[Federal Register Volume 83, Number 15 (Tuesday, January 23, 2018)]
[Notices]
[Page 3112]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-01141]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[S-147-2017]


Approval of Subzone Status; Plaza Warehousing & Realty 
Corporation; Caguas, Puerto Rico

    On September 20, 2017, the Executive Secretary of the Foreign-Trade 
Zones (FTZ) Board docketed an application submitted by the Puerto Rico 
Trade and Export Company, grantee of FTZ 61, requesting subzone status 
subject to the existing activation limit of FTZ 61, on behalf of Plaza 
Warehousing & Realty Corporation, in Caguas, Puerto Rico.
    The application was processed in accordance with the FTZ Act and 
Regulations, including notice in the Federal Register inviting public 
comment (82 FR 44558, September 25, 2017). The FTZ staff examiner 
reviewed the application and determined that it meets the criteria for 
approval.
    Pursuant to the authority delegated to the FTZ Board's Executive 
Secretary (15 CFR Sec. 400.36(f)), the application to establish Subzone 
61T was approved on January 18, 2018, subject to the FTZ Act and the 
Board's regulations, including Section 400.13, and further subject to 
FTZ 61's 1,821.07-acre activation limit.

    Dated: January 18, 2018.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2018-01141 Filed 1-22-18; 8:45 am]
 BILLING CODE 3510-DS-P
STATE of Louisiana v. Hank Allen MORAN aka-Hank Moran

NO. 2017-KO-1000

Supreme Court of Louisiana.

April 16, 2018

Denied.
EXHIBIT 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Armitage Mining Corp. (the "Company") on
Form 10-KSB for the year ending September 30, 2005 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Laurence
Stephenson, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002,
that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS WHEREOF, the undersigned has executed this certification as of the
27th day of October, 2005.


/s/  Laurence Stephenson
---------------------------------
Chief Financial Officer
EXHIBIT 31.1  SECTION 302 CERTIFICATION
 CERTIFICATION
  1.
    
    I have reviewed this report on Form 10-K and all reports on Form 8-K
required to be filed in respect of the period covered by this report
on Form 10-K of Hartford Life Global Funding Trust 2004-001 (the
Exchange Act periodic reports);2.
    
    Based on my knowledge, the Exchange Act periodic reports, taken as a
whole, do not contain any untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements
made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this
report;3.
    
    Based on my knowledge, all of the distribution, servicing and other
information required to be provided under Form 8-K for the period
covered by this report is included in the Exchange Act periodic
reports;4.
    
    Based on my knowledge and the servicer compliance statement required
in this report under Item 1123 of Regulation AB, and except as
disclosed in the Exchange Act periodic reports, the servicer has
fulfilled its obligations under the servicing agreement in all
material respects;5.
    
    All of the reports on assessment of compliance with servicing criteria
for asset-backed securities and their related attestation reports on
assessment of compliance with servicing criteria for asset-backed
securities required to be included in this report in accordance with
Item 1122 of Regulation AB and Exchange Act Rule 13a-18 and 15d-18
have been included as an exhibit to this report, except as otherwise
disclosed in this report. Any material instances of noncompliance
described in such reports have been disclosed in this report on Form
10-K.
    /s/ Kenneth A. McCullumKenneth A. McCullumSenior officer in charge of securitizationHartford Life Insurance Company, as depositor
**CERTIFICATION**




I,
      Elizabeth Plaza, certify that:




1.
      I have
      reviewed this annual report on Form 10-KSB of Pharma-Bio Serv, Inc. ("Pharma-Bio
      Serv");




2.
      Based
      on my knowledge, this annual report does not contain any untrue statement of
      a
      material fact or omit to state a material fact necessary to make the statements
      made, in light of the circumstances under which such statements were made,
      not
      misleading with respect to the period covered by this annual
      report;




3.
      Based
      on my knowledge, the financial statements, and other financial information
      included in this annual report, fairly present in all material respects the
      financial condition, results of operations and cash flows of Pharma-Bio Serv
      as
      of and for, the periods presented in this annual report;




4.
      Pharma-Bio Serv's other certifying officer and I are responsible for
      establishing and maintaining disclosure controls and procedures (as defined
      in
      Exchange Act Rules 13a-15(e) and 15(d)-15(e) for Pharma-Bio Serv and
      have:




a.
      Designed such disclosure controls and procedures, or caused such disclosure
      controls and procedures to be designed under our supervision, to ensure that
      material information relating to Pharma-Bio Serv, including its consolidated
      subsidiaries, is made known to us by others within those entities, particularly
      during the period in which this annual report is being prepared;




b.
      Evaluated the effectiveness of Pharma-Bio Serv's disclosure controls and
      procedures and presented in this report our conclusions about the effectiveness
      of the disclosure controls and procedures, as of the end of the period covered
      by this report based on such evaluation; and




c.
      Disclosed in this report any change in Pharma-Bio Serv's internal control over
      financial reporting that occurred during its fourth fiscal quarter that has
      materially affected, or is reasonably likely to materially affect, Pharma-Bio
      Serv's internal control over financial reporting.




5.
      Pharma-Bio Serv's other certifying officer and I have disclosed, based on our
      most recent evaluation of internal control over financial reporting to
      Pharma-Bio Serv's auditors and the audit committee of Pharma-Bio Serv's board
      of
      directors (or persons performing the equivalent functions):




a.
      All
      significant deficiencies and material weaknesses in the design or operation
      of
      internal control over financial reporting which are reasonably likely to
      adversely affect Pharma-Bio Serv's ability to record, process, summarize and
      report financial information; and




b.
      Any
      fraud, whether or not material, that involves management or other employees
      who
      have a significant role in Pharma-Bio Serv's internal controls over financial
      reporting.




/s/
                Elizabeth PlazaElizabeth
                PlazaChief
                Executive Officer





Dated:
      January 31, 2008
Director Compensation Arrangements



 Exhibit 10.15 
 2007 DIRECTOR COMPENSATION PACKAGE 
 On May 31, 2007, the Board of Directors of Radiant Systems, Inc.
(the “Company”) approved a new compensation package for the members of the Board of Directors and its committees effective July 1, 2007. 
 Each non-employee director will be paid an annual retainer of $30,000. A $10,000 annual retainer will be paid to the Audit Committee and Compensation Committee Chairmen and a $5,000 annual retainer will be paid to the Chairman of any other
committee. An annual retainer of $5,000 will be paid to each Audit Committee and Compensation Committee member other than the Chairmen. All cash retainers shall be paid quarterly. 
 Each non-employee director of the Company will receive an annual grant of options to purchase 10,000 shares of the Company’s common stock on the last business day of each fiscal year of the Company. In addition,
all new non-employee directors of the Company receive a one-time grant of an option to purchase 25,000 shares of the Company’s common stock at an exercise price equal to the fair market value of the stock on the date of grant, which options
vest over a period of three years. All such options expire, unless previously exercised or terminated, ten years from the date of grant.
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

September 26, 2006 Clifford W. Taylor,
Chief Justice

130970 Michael F. Cavanagh

Elizabeth A. Weaver Marilyn Kelly Maura D. Corrigan Robert P. Young, Jr. TAMEKA BRANCHE, Personal Stephen J. Markman, Representative of the Estate of Justices Tommie Charles Tyson, Deceased, Plaintiff-Appellee,

v SC: 130970 COA: 266467 Wayne CC: 05-514262-NH SINAI-GRACE HOSPITAL, a/k/a SINAI HOSPITAL OF GREATER DETROIT, Defendant-Appellee,

and

DANIEL J. WALZ, M.D., Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the March 9, 2006 order of the Court of Appeals is considered and, it appearing to this Court that the case of Washington v Sinai Hosp ital of Greater Detroit (Docket No. 130641) is pending on appeal before this Court and that the decision in that case may resolv e an issue raised in the present application for leave to appeal, we ORDER that the application be held in ABEYANCE pending the decision in that case.

l0918 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

September 26, 2006

Clerk
EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION
                      906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Annual Report of Pride, Inc. (the "Company") on Form
10-KSB for the fiscal year ended June 30, 2006, as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Michael L. Schumacher,
Chief Executive Officer and Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, to the best of my knowledge:

     (1) The Report fully complies with the requirements of Section 13(a) or
15(d), as applicable, of the Securities and Exchange Act of 1934; and

     (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.


/s/ Michael L. Schumacher
Michael L. Schumacher

President, Treasurer, Chief Executive Officer
 and Chief Financial Officer

March 1, 2007



                                       17